Lowering Events in Non-proliferative Retinopathy in Scotland
Status:
Active, not recruiting
Trial end date:
2023-08-01
Target enrollment:
Participant gender:
Summary
LENS is a streamlined multicentre randomized placebo-controlled parallel-group trial
investigating the effect of fenofibrate treatment on the progression of diabetic
retinopathy/maculopathy
Phase:
Phase 4
Details
Lead Sponsor:
University of Oxford
Collaborators:
National Institute for Health Research, United Kingdom NHS Scotland Diabetic Retinopathy Screening Collaborative University of Aberdeen University of Dundee University of Edinburgh University of Glasgow